Atlas Trials

H. Lee Moffitt Cancer Center and Research Institute

539 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch H. Lee Moffitt Cancer Center and Research Institute

RecordFirmDate
Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract (NCT04069299)H. Lee Moffitt Cancer Center and Research Institute2019-09-25
Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery (NCT04091165)H. Lee Moffitt Cancer Center and Research Institute2019-09-23
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion (NCT03722407)H. Lee Moffitt Cancer Center and Research Institute2019-08-28
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma (NCT03381183)H. Lee Moffitt Cancer Center and Research Institute2019-08-21
Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma (NCT03921073)H. Lee Moffitt Cancer Center and Research Institute2019-08-20
Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas (NCT04055688)H. Lee Moffitt Cancer Center and Research Institute2019-08-15
Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance (NCT04101526)H. Lee Moffitt Cancer Center and Research Institute2019-08-15
Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma (NCT03927274)H. Lee Moffitt Cancer Center and Research Institute2019-06-20
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease (NCT03719768)H. Lee Moffitt Cancer Center and Research Institute2019-06-10
Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer (NCT03923270)H. Lee Moffitt Cancer Center and Research Institute2019-06-06
Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers (NCT03598309)H. Lee Moffitt Cancer Center and Research Institute2019-06-05
Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia (NCT03514017)H. Lee Moffitt Cancer Center and Research Institute2019-05-31
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma (NCT03834623)H. Lee Moffitt Cancer Center and Research Institute2019-05-14
Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer (NCT03874325)H. Lee Moffitt Cancer Center and Research Institute2019-04-26
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia (NCT03760523)H. Lee Moffitt Cancer Center and Research Institute2019-04-18
Prospective Study of Personalized Approach to Inpatient Patients With Hyperglycemia (NCT03904199)H. Lee Moffitt Cancer Center and Research Institute2019-04-04
Florida Pancreas Collaborative Next Generation Biobank (NCT03851133)H. Lee Moffitt Cancer Center and Research Institute2019-03-04
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease (NCT03605927)H. Lee Moffitt Cancer Center and Research Institute2019-02-15
IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors (NCT03758781)H. Lee Moffitt Cancer Center and Research Institute2019-02-13
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC (NCT03611738)H. Lee Moffitt Cancer Center and Research Institute2019-02-01
Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases (NCT03807765)H. Lee Moffitt Cancer Center and Research Institute2019-01-30
Emotional Support Messages Following a Cancer Diagnosis (NCT03840109)H. Lee Moffitt Cancer Center and Research Institute2019-01-30
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer (NCT03614949)H. Lee Moffitt Cancer Center and Research Institute2019-01-29
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation (NCT03734666)H. Lee Moffitt Cancer Center and Research Institute2019-01-14
Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1 (NCT03630809)H. Lee Moffitt Cancer Center and Research Institute2019-01-10
TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT03686488)H. Lee Moffitt Cancer Center and Research Institute2018-12-20
Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) (NCT03663166)H. Lee Moffitt Cancer Center and Research Institute2018-11-20
Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer (NCT03748719)H. Lee Moffitt Cancer Center and Research Institute2018-11-19
Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer (NCT03712943)H. Lee Moffitt Cancer Center and Research Institute2018-10-23
Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia (NCT03575325)H. Lee Moffitt Cancer Center and Research Institute2018-10-11
Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide (NCT03411031)H. Lee Moffitt Cancer Center and Research Institute2018-10-04
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy (NCT03543189)H. Lee Moffitt Cancer Center and Research Institute2018-10-03
Use of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers (NCT03656133)H. Lee Moffitt Cancer Center and Research Institute2018-09-26
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer (NCT03511196)H. Lee Moffitt Cancer Center and Research Institute2018-09-17
Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients (NCT03674138)H. Lee Moffitt Cancer Center and Research Institute2018-09-12
Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer (NCT03630120)H. Lee Moffitt Cancer Center and Research Institute2018-08-06
Applying mHealth to Tobacco-related Health Disparities (NCT03404596)H. Lee Moffitt Cancer Center and Research Institute2018-07-16
Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung (NCT02466568)H. Lee Moffitt Cancer Center and Research Institute2018-07-01
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma (NCT03501368)H. Lee Moffitt Cancer Center and Research Institute2018-06-27
Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma (NCT03543969)H. Lee Moffitt Cancer Center and Research Institute2018-06-14
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer (NCT03387553)H. Lee Moffitt Cancer Center and Research Institute2018-06-06
Improving Sleep in BMT Survivors (NCT03537963)H. Lee Moffitt Cancer Center and Research Institute2018-05-15
Community Colorectal Cancer Awareness, Research, Education & Screening (C-CARES) (NCT03906110)H. Lee Moffitt Cancer Center and Research Institute2018-04-03
Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma (NCT03426891)H. Lee Moffitt Cancer Center and Research Institute2018-03-16
Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) (NCT03406715)H. Lee Moffitt Cancer Center and Research Institute2018-03-15
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer (NCT03384914)H. Lee Moffitt Cancer Center and Research Institute2018-02-19
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer (NCT03377023)H. Lee Moffitt Cancer Center and Research Institute2018-02-02
Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers (NCT03332498)H. Lee Moffitt Cancer Center and Research Institute2018-01-24
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma (NCT03370276)H. Lee Moffitt Cancer Center and Research Institute2017-12-20
Phase II Study of Pembrolizumab and Lenvatinib in Advanced Well-differentiated Neuroendocrine Tumors (NCT03290079)H. Lee Moffitt Cancer Center and Research Institute2017-12-15
Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer (NCT03137693)H. Lee Moffitt Cancer Center and Research Institute2017-11-29
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer (NCT03215810)H. Lee Moffitt Cancer Center and Research Institute2017-10-11
Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC (NCT03177291)H. Lee Moffitt Cancer Center and Research Institute2017-09-26
Facilitating Smoking Cessation With Reduced Nicotine Cigarettes (NCT02796391)H. Lee Moffitt Cancer Center and Research Institute2017-09-07
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma (NCT02780609)H. Lee Moffitt Cancer Center and Research Institute2017-07-20
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer (NCT03112590)H. Lee Moffitt Cancer Center and Research Institute2017-06-23
Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population (NCT03176576)H. Lee Moffitt Cancer Center and Research Institute2017-06-13
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression (NCT02891603)H. Lee Moffitt Cancer Center and Research Institute2017-06-08
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat (NCT02802163)H. Lee Moffitt Cancer Center and Research Institute2017-06-01
Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms (NCT03072043)H. Lee Moffitt Cancer Center and Research Institute2017-05-18
Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative (NCT05064410)H. Lee Moffitt Cancer Center and Research Institute2017-05-11
Refining and Testing the Electronic Social Network Assessment Program (eSNAP) (NCT03026699)H. Lee Moffitt Cancer Center and Research Institute2017-05-05
Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer (NCT02779855)H. Lee Moffitt Cancer Center and Research Institute2017-05-02
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer (NCT02964078)H. Lee Moffitt Cancer Center and Research Institute2017-04-25
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma (NCT02989870)H. Lee Moffitt Cancer Center and Research Institute2017-03-27
Biobank for African American Prostate Cancer Research in Florida (NCT03232411)H. Lee Moffitt Cancer Center and Research Institute2017-03-22
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma (NCT03071406)H. Lee Moffitt Cancer Center and Research Institute2017-03-14
Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder (NCT02901548)H. Lee Moffitt Cancer Center and Research Institute2017-02-16
Oncology Research Information Exchange Network (ORIEN) Lung Cancer Study (NCT02803333)H. Lee Moffitt Cancer Center and Research Institute2017-02-16
Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer (NCT03043599)H. Lee Moffitt Cancer Center and Research Institute2017-02-13
FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas (NCT03042780)H. Lee Moffitt Cancer Center and Research Institute2017-02-01
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT (NCT03018223)H. Lee Moffitt Cancer Center and Research Institute2017-01-31
Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors (NCT02948946)H. Lee Moffitt Cancer Center and Research Institute2017-01-09
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma (NCT02945800)H. Lee Moffitt Cancer Center and Research Institute2016-10-25
Spanish-Language Smoking Cessation Trial (NCT02945787)H. Lee Moffitt Cancer Center and Research Institute2016-10-24
Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer (NCT02973750)H. Lee Moffitt Cancer Center and Research Institute2016-10-20
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma (NCT02935309)H. Lee Moffitt Cancer Center and Research Institute2016-10-14
Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers (NCT02829918)H. Lee Moffitt Cancer Center and Research Institute2016-10-05
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) (NCT02851056)H. Lee Moffitt Cancer Center and Research Institute2016-09-27
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma (NCT02721459)H. Lee Moffitt Cancer Center and Research Institute2016-09-07
Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas (NCT02829931)H. Lee Moffitt Cancer Center and Research Institute2016-08-22
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma (NCT02631590)H. Lee Moffitt Cancer Center and Research Institute2016-07-05
Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT) (NCT02722941)H. Lee Moffitt Cancer Center and Research Institute2016-06-10
A Combined Cell Therapy Approach to the Treatment of Neuroblastoma (NCT02745756)H. Lee Moffitt Cancer Center and Research Institute2016-04-14
Validation Study on the Impact of Decipher® Testing - VANDAAM Study (NCT02723734)H. Lee Moffitt Cancer Center and Research Institute2016-04-13
Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC) (NCT02638090)H. Lee Moffitt Cancer Center and Research Institute2016-03-22
Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma (NCT02652455)H. Lee Moffitt Cancer Center and Research Institute2016-03-08
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma (NCT02611037)H. Lee Moffitt Cancer Center and Research Institute2016-03-04
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention (NCT02588339)H. Lee Moffitt Cancer Center and Research Institute2016-03-04
Fermented Wheat Germ Extract in Women With Ovarian Cancer (NCT02411565)H. Lee Moffitt Cancer Center and Research Institute2016-03-01
TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer (NCT02586675)H. Lee Moffitt Cancer Center and Research Institute2016-02-23
Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide (NCT02502864)H. Lee Moffitt Cancer Center and Research Institute2016-02-09
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer (NCT02572284)H. Lee Moffitt Cancer Center and Research Institute2016-01-27
Dose Dense Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Ovarian Cancer (NCT02440425)H. Lee Moffitt Cancer Center and Research Institute2015-10-20
Smoking-cessation: A Spanish-Language Clinical Trial (NCT02611076)H. Lee Moffitt Cancer Center and Research Institute2015-10-15
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer (NCT02513563)H. Lee Moffitt Cancer Center and Research Institute2015-10-13
Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors (NCT02575300)H. Lee Moffitt Cancer Center and Research Institute2015-10-09
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention (NCT02592447)H. Lee Moffitt Cancer Center and Research Institute2015-09-29
Using MC1R Genotype to Impact Melanoma Risk Behavior (NCT03509467)H. Lee Moffitt Cancer Center and Research Institute2015-08-03
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas (NCT02313272)H. Lee Moffitt Cancer Center and Research Institute2015-07-28
← Previous Next →

Track H. Lee Moffitt Cancer Center and Research Institute automatically

Every clearance here is in the API, with alerts when new ones post.